US2010130481A1PendingUtilityA1
Anticonvulsant and anxiolytic methods of using receptor subtype selective agents
Est. expiryMar 28, 2022(expired)· nominal 20-yr term from priority
A61P 25/00A61P 25/18A61P 25/22A61P 1/08C07D 471/04C07D 495/04C07D 487/04C07D 243/24C07D 487/06C07D 243/12C07D 495/14C07D 498/04C07D 519/00C07D 243/20C07D 243/14
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of using orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anticonvulsant and anxiolytic activity with reduced sedative, hypnotic, muscle relaxant, or ataxic effects.
Claims
exact text as granted — not AI-modified1 . A method for the treatment and/or prevention of convulsions comprising:
administering to a mammalian subject in need of such treatment an effective amount of a compound of formula VIII, or a salt thereof,
wherein X is N or CH; Y and Z are taken together with the two intervening carbon atoms to form a ring selected from phenyl and thienyl, which ring is substituted at the C(8) position with at least the substituent —C≡C—R, where R is H, Si(CH 3 ) 3 , t-butyl, isopropyl, methyl, or cyclopropyl; R 1 is H, CH 3 , CF 3 , CH 2 CH 3 , CH 2 CF 3 , or cyclopropyl; R 2 is a substituted or unsubstituted at least partially unsaturated 5 or 6 membered cyclic or heterocyclic ring, wherein if substituted, the substituent is F, Cl, Br, or NO 2 at the 2′-position.
2 . The method according to claim 1 , wherein the compound is
wherein R is H or Si(CH 3 ) 3 , R′ is H or CH 3 , and X′ is H, F, Cl, Br, or NO 2 .
3 . The method according to claim 1 , wherein the compound is
4 . A method for the treatment and/or prevention of anxiety comprising:
administering to a mammalian subject in need of such treatment an effective amount of a compound of formula VIII, or a salt thereof,
wherein: X is N or CH; Y and Z are taken together with the two intervening carbon atoms to form a ring selected from phenyl and thienyl, which ring is substituted at the C(8) position with at least the substituent —C≡C—R, where R is H, Si(CH 3 ) 3 , t-butyl, isopropyl, methyl, or cyclopropyl; R 1 is H, CH 3 , CF 3 , CH 2 CH 3 , CH 2 CF 3 , or cyclopropyl; R 2 is a substituted or unsubstituted at least partially unsaturated 5 or 6 membered cyclic or heterocyclic ring, wherein if substituted, the substituent is F, Cl, Br, or NO 2 at the 2′-position.
5 . The method according to claim 4 , wherein the compound is
wherein R is H or Si(CH 3 ) 3 , R′ is H or CH 3 , and X′ is H, F, Cl, Br, or NO 2 .
6 . The method according to claim 4 , wherein the compound isCited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.